RxDoctor Payments Data

John Oconnor, MD

Radiation Oncology · Los Angeles, CANPI 1396709721

Payments from drug & device makers

$47in general payments, 2019–2025

Across 2 payments — averaging $23.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Incyte Corporation$24
  • Geron Corporation$23

What the payments were for

  • Food & beverage$47100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Incyte Corporation1$24
Geron Corporation1$23

How this compares

$47 in reported general payments places this provider in the 10th percentile of 627 radiation oncology providers in California.

See all radiation oncology providers in California

Medicare billing

Part B allowed, 2024
$792,698
Medicare patients
202
Services billed
7,755

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mometasone Furoate35$835

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →